Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Wang

P2.01-100 Different Genetic Mutations Enriched in Circulating Tumor DNA Predict Different Metastatic Sites in Lung Adenocarcinoma Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-16 Dynamic ctDNA Monitoring Revealed Novel Resistance Mechanisms and Response Predictors of Osimertinib Treatment in East Asian NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial

Journal of Thoracic Oncology

Respiratory Medicine

English

P048 Clinical Efficacy of Osimertinib Mesylate Tablets in Treatment of Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

OA 07.01 a Prospective Study of Perioperative Rapid Clearance of Circulating Tumor DNA in R0 Resected Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

MA06.07 Genetic and Epigenetic Alterations Are Associated With Tumor Mutation Burden in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-65 First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients With EGFR-Mutant Metastatic NSCLC Receiving TKIs

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-01 Prospective Comparison of Four Plasma Testing Platforms for T790M and Effectiveness of Osimertinib in Chinese NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English